Eric Swayze
EVP Research · 5 filings · Latest: Jun 25, 2026
IONIS PHARMACEUTICALS INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
IONS | Eric Swayze | EVP Research | Jun 25, 2026 | Sale | $79.18 | 10,602 | $839.5K | 21,759 | |
IONS | Swayze Eric | — | Jun 25, 2026 | Proposed Sale | $79.16 | 10,602 | $839.3K | — | |
IONS | Eric Swayze | EVP Research | Feb 13, 2026 | Sale | $81.76 | 15,642 | $1.3M | 32,105 | |
IONS | Swayze Eric | — | Feb 13, 2026 | Proposed Sale | $81.65 | 15,642 | $1.3M | — | |
IONS | Eric Swayze | EVP Research | Jan 30, 2026 | Sale | $82.93 | 6,179 | $512.4K | 47,747 | |
IONS | Swayze Eric | — | Jan 30, 2026 | Proposed Sale | $83.01 | 6,179 | $512.9K | — | |
IONS | Eric Swayze | EVP Research | Jan 16, 2026 | Sale | $75.34 | 9,933 | $748.4K | 318 | |
IONS | Eric Swayze | EVP Research | Jan 15, 2026 | Option Exercise | $0.00 | 21,477 | — | 367 | |
IONS | Swayze Eric | — | Jan 16, 2026 | Proposed Sale | $76.23 | 9,884 | $753.5K | — | |
IONS | Swayze Eric | — | Jan 2, 2026 | Proposed Sale | $69.02 | 23,463 | $1.6M | — | |
IONS | Swayze Eric | — | Oct 6, 2025 | Proposed Sale | $69.02 | 6,849 | $472.7K | — | |
IONS | Swayze Eric | — | Oct 1, 2025 | Proposed Sale | $66.00 | 27,114 | $1.8M | — | |
IONS | Swayze Eric | — | Sep 2, 2025 | Proposed Sale | $49.67 | 11,130 | $552.9K | — | |
IONS | Swayze Eric | — | Jan 31, 2025 | Proposed Sale | $35.00 | 1,857 | $65.0K | — | |
IONS | Swayze Eric | — | Jan 16, 2025 | Proposed Sale | $32.70 | 7,154 | $233.9K | — | |
IONS | Swayze Eric | — | Nov 12, 2024 | Proposed Sale | $38.88 | 1,194 | $46.4K | — | |
IONS | Swayze Eric | — | Feb 2, 2024 | Proposed Sale | $49.56 | 1,940 | $96.1K | — | Sep 5 1:19 AM 144/A |